Literature DB >> 3006110

Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure.

J De Vry, J L Slangen.   

Abstract

In experiment 1, rats (n = 12) were trained to discriminate the benzodiazepine (BDZ) compound chlordiazepoxide (CDP, 20 mg/kg, IP) from saline in a two-lever food-reinforced procedure, and subsequently were tested for stimulus control with different doses of CDP, Ro 15-1788 (a proposed BDZ receptor antagonist) and Ro 15-1788 plus 20 mg/kg CDP. Ro 15-1788 (0.63-40 mg/kg) dose-dependently antagonized CDP, and induced predominantly saline appropriate responding when administered alone. Thereafter, the same rats were retrained by progressively decreasing the training dose, to discriminate 2.5 mg/kg CDP from saline, and were tested again with the same compounds. Ro 15-1788 (0.16-40 mg/kg) now failed to antagonize CDP (2.5 mg/kg) and increased the percentage of drug-appropriate responding in a dose-related manner when administered alone. In experiment 2, separate groups of rats (n = 10) were similarly trained to discriminate either 15 or 3 mg/kg CDP from saline. Tests with CDP, Ro 15-1788 and Ro 15-1788 plus CDP (either 15 or 3 mg/kg) yielded similar results to experiment 1, suggesting that the training dose effects on generalization and antagonism of Ro 15-1788 were not affected by the manner in which the lower CDP dose acquired drug stimulus control. It is concluded that mixed agonist-antagonist properties are apparent after variations of the BDZ training dose in a drug discrimination procedure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006110     DOI: 10.1007/bf00652236

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Discriminable effects of benzodiazepines.

Authors:  D A Overton
Journal:  Psychopharmacol Commun       Date:  1976

2.  Theoretical and methodological considerations on drug discrimination learning.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Psychopharmacologia       Date:  1976-03-16

3.  Specific proconvulsant action of an imidazobenzodiazepine (RO 15-1788) on isoniazid convulsions.

Authors:  M G Corda; E Costa; A Guidotti
Journal:  Neuropharmacology       Date:  1982-01       Impact factor: 5.250

4.  The role of fentanyl training dose and of the alternative stimulus condition in drug generalization.

Authors:  W Koek; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  Differential interactions between chlordiazepoxide, pentobarbital and benzodiazepine antagonists Ro 15-1788 and CGS 8216 in a drug discrimination procedure.

Authors:  J De Vry; J L Slangen
Journal:  Pharmacol Biochem Behav       Date:  1986-04       Impact factor: 3.533

6.  The benzodiazepine antagonist, Ro 15-1788, increases REM and slow wave sleep in the dog.

Authors:  A Wauquier; D Ashton
Journal:  Brain Res       Date:  1984-08-06       Impact factor: 3.252

7.  Generalization between benzodiazepine- and triazolopyridazine-elicited discriminative cues.

Authors:  J F McElroy; R S Feldman
Journal:  Pharmacol Biochem Behav       Date:  1982-10       Impact factor: 3.533

8.  Role of training dose in discrimination of nicotine and related compounds by rats.

Authors:  I P Stolerman; H S Garcha; J A Pratt; R Kumar
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Stimulus control induced by benzodiazepine antagonist Ro 15-1788 in the rat.

Authors:  J De Vry; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Benzodiazepine receptor mediated discriminative cues: effects of GABA-ergic drugs and inverse agonists.

Authors:  E B Nielsen; J D Valentine; A M Holohean; J B Appel
Journal:  Life Sci       Date:  1983-11-28       Impact factor: 5.037

View more
  13 in total

1.  Reversal of overshadowing in a drug mixture discrimination in rats.

Authors:  J A White; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Effects of several benzodiazepines, alone and in combination with flumazenil, in rhesus monkeys trained to discriminate pentobarbital from saline.

Authors:  W L Woolverton; M A Nader
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 4.  Role of training dose in drug discrimination: a review.

Authors:  Ian P Stolerman; Emma Childs; Matthew M Ford; Kathleen A Grant
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

5.  Sensitivity of pentylenetetrazol discrimination increased by a stimulus fading technique.

Authors:  C M Harris; M W Emmett-Oglesby; H Lal
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Midazolam cue in rats: effects of Ro 15-1788 and picrotoxin.

Authors:  I P Stolerman; H S Garcha; I C Rose
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Discriminative stimulus properties of midazolam: comparison with other benzodiazepines.

Authors:  F Woudenberg; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Empirical evidence that the state dependence and drug discrimination paradigms can generate different outcomes.

Authors:  F C Colpaert; W Koek
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

9.  Antagonism of the ethanol-like discriminative stimulus effects of ethanol, pentobarbital, and midazolam in cynomolgus monkeys reveals involvement of specific GABA(A) receptor subtypes.

Authors:  Christa M Helms; Laura S M Rogers; Kathleen A Grant
Journal:  J Pharmacol Exp Ther       Date:  2009-07-29       Impact factor: 4.030

10.  Stimulus control induced by benzodiazepine antagonist Ro 15-1788 in the rat.

Authors:  J De Vry; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.